Related Experiment Video
Updated: Jun 5, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Angiogenic factors and preeclampsia.
Sharon E Maynard1, S Ananth Karumanchi
1Department of Medicine, Division of Renal Diseases and Hypertension, George Washington University School of Medicine and Health Sciences, Washington, DC, USA. smaynard@alumni.princeton.edu
Seminars in Nephrology
|January 27, 2011
Summary
Preeclampsia, a pregnancy disorder, stems from placental anti-angiogenic factors like soluble Flt1 and soluble endoglin. These factors cause maternal endothelial dysfunction, leading to hypertension and other symptoms.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Cardiovascular Biology
Background:
- Preeclampsia is a pregnancy-specific hypertensive disorder.
- It involves systemic maternal endothelial dysfunction originating in the placenta.
- The molecular pathogenesis was previously unclear.
Purpose of the Study:
- To explore the role of placental anti-angiogenic factors in preeclampsia.
- To understand the molecular mechanisms underlying preeclampsia.
- To investigate the link between angiogenic factors and placental vascular development.
Main Methods:
- Observational study analyzing maternal circulation.
- Measurement of placental anti-angiogenic factors (soluble Flt1, soluble endoglin).
- Correlation of factor levels with clinical manifestations of preeclampsia.
Main Results:
- Increased levels of soluble Flt1 and soluble endoglin in maternal circulation precede preeclampsia onset.
- These factors are implicated in causing systemic endothelial dysfunction.
- Endothelial dysfunction leads to hypertension, proteinuria, and other preeclampsia symptoms.
Conclusions:
- Altered expression of placental anti-angiogenic factors is a key mechanism in preeclampsia.
- Soluble Flt1 and endoglin contribute to the disease's clinical features.
- Understanding these factors has significant clinical implications for detection and treatment.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...